Mavacamten therapy in hypertrophic obstructive cardiomyopathy revealing severe aortic stenosis: a case highlighting diagnostic complexity

11 May 2026 (12:41 - 12:52)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Mrs Georgiana Dumitru Ionescu

Clinical Hospital Dr Theodor Burghele, Bucharest (Romania)

3 More presentations in this session

Presentation thumbnail

Mavacamten for symptomatic mid-ventricular obstruction in apical hypertrophic cardiomyopathy

Doctor H. Choi (Seoul, KR)

Presentation thumbnail

Expanding the role of myosin inhibition: mavacamten in apical hypertrophic cardiomyopathy with mid-ventricular obstruction

Doctor J. Fernandes Pedro (Lisbon, PT)

Presentation thumbnail

Long-term clinical benefit of mavacamten for hypertrophic cardiomyopathy in a patient with RAF1-associated noonan syndrome

Mrs H. Seghers (Edegem, BE)

Access the full session

Session thumbnail

Myosin inhibition in hypertrophic cardiomyopathy: beyond the classic left ventricular outflow tract story

The Event

Event poster

Heart Failure 2026

11 May 2026 12:41 CET

You may be interested in

Congress Presentation

Effects of Mavacamten use in a patient with hypertrophic obstructive cardiomyopathy and extremely high resting left ventricular outflow tract gradient

Congress Presentation

A case of symptomatic obstructive hypertrophic cardiomyopathy in late life: multimodality imaging to guide a tailored pharmacologic approach

Congress Presentation

Obstruction-driven HFpEF in hypertrophic cardiomyopathy: a multimodal, guideline-based approach

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources